Bhageria Industries reported a strong fiscal year 2025-26 with standalone total income up 45.9% to ₹880.56 crore. The company also recommended a higher dividend of ₹2.50 per share. This growth was driven by its chemicals segment operating at high capacity.
Bhageria Industries Reports Robust FY2025-26 Results
Bhageria Industries' standalone total income surged by 45.9% to ₹880.56 crore in fiscal year 2025-26, up from ₹604.07 crore in the previous year. Net profit after tax (PAT) rose 19% to ₹50.30 crore.
Reader Takeaway: Strong chemical segment performance drives revenue; monitor pharma segment's long-term R&D progress.
What just happened
Bhageria Industries announced its full-year financial results for FY 2025-26, showcasing significant year-on-year growth in both income and profits. The company's total standalone income reached ₹880.56 crore, a 45.9% increase from FY 2024-25. Net Profit After Tax (PAT) saw a 19% jump to ₹50.30 crore, with Earnings Per Share (EPS) improving to ₹11.52 from ₹9.68.
Why this matters
The robust financial performance, particularly the strong revenue growth in the chemicals segment due to high capacity utilization, indicates operational efficiency. The recommended increase in dividend payout also signals management's confidence in future cash flows and commitment to shareholder returns.
The backstory
Bhageria Industries has achieved three consecutive years of revenue growth following a dip in FY23/FY24. The company's strategy focuses on disciplined organic growth, emphasizing capacity expansion within its core chemical and pharmaceutical businesses rather than acquisitions.
What changes now
With new capacities coming online, including expanded H-Acid manufacturing and commencement of plasticizer production, the company is poised to benefit from incremental revenue streams. The commissioning of additional solar power capacity also contributes to its renewable energy portfolio.
Risks to watch
The pharmaceutical segment remains a long-term R&D initiative with a currently modest contribution to overall results. Investors will be keen to see its future impact.
Peer comparison
While specific peer data was not provided in the filing, Bhageria's strong performance in the chemicals sector, with high capacity utilization, suggests it is leveraging its operational strengths effectively.
Context metrics (time-bound)
For FY 2025-26, standalone total income was ₹880.56 crore (up 45.9% YoY), PAT was ₹50.30 crore (up 19% YoY), and EPS was ₹11.52 (up 19% YoY). EBITDA stood at ₹102.25 crore with an 11.61% margin. The recommended dividend is ₹2.50 per share.
What to track next
Investors should closely monitor the ramp-up and revenue contribution from the new plasticizer production and expanded H-Acid capacity. The performance and progress of the pharmaceutical segment's R&D pipeline will also be key.